Sanrabine IV infusion 200mg is an injectable drug from Asahi Kasei Pharma. It contains Enocitabine, a nucleoside analog chemotherapy agent used for treating certain cancers like acute myeloid leukemia (AML). It has a YJ code of 4224402D2032 and is standardized as 200mg 1 bottle.
Sanrabine IV infusion 200mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →